340B Contract Pharmacy Arrangements: What Does the Future Hold? Structuring Arrangements, Meeting Legal and Regulatory Requirements

Name: 340B Contract Pharmacy Arrangements: What Does the Future Hold? Structuring Arrangements, Meeting Legal and Regulatory Requirements
Start: 2021-01-27T13:00:00-05:00
End: 2021-01-27T14:30:00-05:00
Location: VIRTUAL

January 27 @ 1:00 pm - 2:30 pm

Join Frier Levitt Life Sciences Partner Jesse C. Dresser, Esq. as part of the panel of healthcare attorneys as they examine contract pharmacy arrangements and the key legal and regulatory concerns when structuring and documenting the arrangements.

Outline

Recent 340B developments: What is the going forward impact on 340B contract pharmacy arrangements
Structuring and implementing contract pharmacy arrangements
1. HRSA essential compliance elements
2. Fee structures
3. Discounts for uninsured patients
4. Reconciliation (including DIR Fees)
340B entity compliance issues
1. Prohibition against diversion
2. Prohibition against duplicate discounts
3. Inventory management issues
Enforcement, sanctions, and litigation

Benefits

The panel will review these and other key issues:

What compliance challenges must be overcome when structuring a contract pharmacy arrangement?
What does the future compliance landscape for contract pharmacy arrangements look like?
What operational and contractual considerations should counsel keep in mind when structuring and implementing these arrangements?

+ Google Calendar + iCal Export